Magnetic Resonance Imaging and Spectroscopy at High Field

NCT ID: NCT00611013

Last Updated: 2013-06-21

Basic Information

• Recruitment Status: WITHDRAWN
• Clinical Phase: NA
• Study Classification: INTERVENTIONAL
• Study Start Date: 2002-06-30

Brief Summary

Evaluating novel MR imaging techniques on volunteers.

Detailed Description

The aim of this study is twofold. The first aim is to evaluate new MRI techniques developed by the investigators of this protocol on human volunteers. The second aim is to assist other investigators who need to use MR images obtained on this device for their own research. MR images and/or spectroscopy data will be acquired from the participants in this protocol.

Conditions

Healthy

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: NONE

Interventions

Magnetic Resonance Imaging

Some participants may receive MRI contrast agent, 0.1 mmol/kg

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Healthy normal volunteers for imaging protocol optimization.

Exclusion Criteria

• Patients with implanted surgical clips (hemostatic clips) or other ferromagnetic material,
• Patients engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or who may have imbedded metal fragments from military activities,
• Patients with permanent (tattoo) eye-liner or with facial make-up (severe eye irritation has been reported),
• Patients with compromised thermoregulatory systems (e.g. certain cancer patients),
• Patients with metallic implants, because they may cause artifacts in diagnostic images due to magnetic field distortion,
• Patients with implanted prosthetic heart valves,
• Patients with pacemakers, neuro-stimulation devices,
• Pregnant patients (the safety of magnetic resonance examination has not been completely established for embryos and fetuses),
• Subjects who have received orthodontic work involving ferromagnetic materials,
• Subjects who have claustrophobia, and
• The patients unwilling to participate in the study or fail to sign the consent form.
• Subjects who are pregnant or breast-feeding will be excluded from the contrast enhanced MRI studies.
• Subjects who had allergic response to contrast agents previously will be excluded from contrast enhanced MRI studies.
• Subjects with known history of asthma, allergic conditions, severe renal insufficiency, sickle cell anemia, chronic hemolytic anemia, gastrointestinal disorders will also be excluded from contrast enhanced MRI studies.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University of California, Irvine

OTHER

Sponsor Role: lead

Responsible Party

Min-Ying (Lydia) Su

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Lutfi T Muftuler, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of California, Irvine

Locations

Center for Functional Onco-Imaging, University of California

Irvine, California, United States

Countries

United States

Other Identifiers

UCI-HS-2002-2611

Identifier Type: -

Identifier Source: org_study_id